BSW Wealth Partners’s Biogen BIIB Stock Holding History

BSW Wealth Partners’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$532K	Buy	2,462 +388	+19%	+$74.2K	0.06%	175
2026 Q1	$380K	Buy	2,074 +165	+9%	+$30.4K	0.05%	208
2025 Q4	$336K	Sell	1,909 -79	-4%	-$12.9K	0.04%	225
2025 Q3	$278K	Buy	+1,988	New	+$269K	0.03%	264
2023 Q1	–	Sell	-757	Closed	-$210K	–	319
2022 Q4	$210K	Buy	+757	New	+$214K	0.05%	272
2018 Q4	–	Sell	-1,025	Closed	-$362K	–	104
2018 Q3	$362K	Buy	+1,025	New	+$353K	0.14%	62

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BSW Wealth Partners's BIIB Position: Q2 2026 in Review

BSW Wealth Partners increased its Biogen (BIIB) stake by 19% in Q2 2026, buying an estimated $74.2K and bringing the position to 2,462 shares worth $532K. The position accounts for 0.06% of the portfolio, ranked #175.

BSW Wealth Partners first reported a position in BIIB in Q3 2018 and has held it in 6 quarters since. 1,038 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

BSW Wealth Partners held 2,462 shares of Biogen worth $532K as of Q2 2026.
BSW Wealth Partners bought 388 Biogen shares in Q2 2026, an estimated $74.2K.
Biogen made up 0.06% of BSW Wealth Partners's portfolio in Q2 2026, its #175 holding.
BSW Wealth Partners first reported a position in Biogen in Q3 2018 and has held it in 6 quarters since.
1,038 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on BSW Wealth Partners's 13F filing for Q2 2026, filed 15 Jul 2026.